openPR Logo
Press release

Malaria Vaccine Market Booms with New WHO Approvals in 2025 | Major Companies are GlaxoSmithKline Biologicals (GSK), the Swiss Serum Institute, WRAIR, Sanaria.

06-26-2025 08:58 AM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Malaria Vaccine Market

Malaria Vaccine Market

Global Malaria Vaccines market is expected to grow at a CAGR Of 31.85% during the forecast period 2024-2031.

The Malaria Vaccines Market takes center stage in DataM Intelligence's latest comprehensive research, where industry experts deliver cutting-edge analysis powered by robust data analytics and strategic market intelligence. This groundbreaking study dives deep into the competitive ecosystem, spotlighting market leaders and their innovative approaches to product development, competitive pricing models, financial performance, and expansion strategies. The research unveils critical market forces, competitive positioning, and breakthrough trends that will define the industry's trajectory in the coming years, providing stakeholders with actionable intelligence to navigate this rapidly evolving marketplace.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access):- https://datamintelligence.com/download-sample/malaria-vaccines-market?rk

The malaria vaccines market comprises all research, development, manufacturing, distribution, and adoption of vaccines targeting Plasmodium parasites, primarily falciparum. It includes both first-generation vaccines like RTS,S/AS01 (Mosquirix) and promising second-generation candidates such as R21/Matrix-M, plus emerging technologies (e.g., whole-sporozoite, mRNA-based) under clinical development .

Key Trends
Next‐generation & combination vaccines
Focus is shifting toward multi-stage and combination vaccines that target both early and blood stages of the parasite's lifecycle.

Nanotechnology & mRNA platforms
Advanced platforms, including nanoparticles and mRNA-based vaccines, are being explored to improve immune response and durability.

Supplier diversification & local production
Efforts are ongoing to build manufacturing capacity in malaria-endemic regions and reduce dependence on single-source suppliers.

Public-private collaboration & AI integration
Strategic partnerships between governments, NGOs, and pharmaceutical firms are accelerating R&D, with AI increasingly used for target discovery.

Malaria Vaccines Market: Industry Giants and Emerging Leaders:

GlaxoSmithKline Biologicals (GSK), the Swiss Serum Institute, WRAIR, Sanaria, BioNTech, Nobelpharma, CellFree Sciences, Sumaya Biotech, VLP Therapeutics LLC, Bharat Biotech, Serum Institute of India, Novavax, Kenya medical research institute.

Malaria Vaccines Industry News:

RTS,S vaccine manufacturers plan to reduce costs to under $5 per dose by 2028, enhancing accessibility.

The R21/Matrix-M vaccine received WHO prequalification and has begun rollout in several African nations.

Serum Institute aims to manufacture up to 200 million doses annually, supporting global supply.

New vaccine candidates using whole-parasite and mRNA technologies are in early-stage trials, showing promising results.

Research Methodology

Our comprehensive research approach leverages a dual-methodology framework that seamlessly integrates qualitative insights with quantitative data analysis to deliver robust market intelligence. The process begins with extensive secondary research, where we meticulously collect information from authoritative industry publications, proprietary databases, and verified market sources. This foundation is strengthened through targeted primary research initiatives, including strategic surveys and in-depth interviews with industry veterans, market experts, and key stakeholders.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/malaria-vaccines-market

Segment Covered in the Malaria Vaccines Market:

By Type of Infectious Agents: Plasmodium Falciparum, Species of Anopheles, P. vivax, P. malaria, Others.

By Type of Vaccines: Erythrocytic, Pre erythrocytic, Multi antigen, Others.

By End User: Hospitals, Speciality Clinics, Retail Pharmacy, Others.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Top-down and bottom-up approach for regional analysis

Regional Analysis for Malaria Vaccines Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)



Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Malaria Vaccines market?

➠ Who are the global key manufacturers of the Malaria Vaccines Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Malaria Vaccines market opportunities and threats faced by the vendors in the global Malaria Vaccines Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Malaria Vaccines market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Looking For Detailed Full Report? Get it here: https://datamintelligence.com/buy-now-page?report=malaria-vaccines-market

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Malaria Vaccine Market Booms with New WHO Approvals in 2025 | Major Companies are GlaxoSmithKline Biologicals (GSK), the Swiss Serum Institute, WRAIR, Sanaria. here

News-ID: 4082699 • Views:

More Releases from DataM Intelligence 4market Research LLP

United States Hyaluronic Acid Market to hit US$ 15.8 billion by 2031 | Top companies - Zimmer Holdings, Inc., Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Inc., F. Merz Aesthetics
United States Hyaluronic Acid Market to hit US$ 15.8 billion by 2031 | Top compa …
The Hyaluronic Acid Market size reached US$ 9.3 billion in 2022 and is expected to reach US$ 15.8 billion by 2031, growing with a CAGR of 7.1% during the forecast period 2024-2031. Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in connective tissues, skin, and synovial fluid, known for its exceptional water-retention capacity holding up to 1,000 times its weight in water. It plays a critical role in tissue hydration,
Japan Leads 2025 Advancements in the Tunnel Field-Effect Transistor (TFET) Market, Projected to Reach US$ 2,253 Million by 2031
Japan Leads 2025 Advancements in the Tunnel Field-Effect Transistor (TFET) Marke …
The Tunnel Field-Effect Transistor (TFET) Market was valued at US$ 949.9 million in 2023 and is projected to reach US$ 2,253.0 million by 2031, growing at a CAGR of 11.4% during the forecast period 2024-2031. Tunnel Field-Effect Transistors (TFETs) are advanced semiconductor devices designed for ultra-low power consumption and high-speed performance. Market growth is driven by increasing demand for energy-efficient electronics, miniaturized components, and next-generation computing technologies. ➠ Download Your Sample Report
United States Leads 2025 Advancements in the Syringes and Needles Market Valued at US$ 8.27 Billion, Set to Hit US$ 13.59 Billion by 2031
United States Leads 2025 Advancements in the Syringes and Needles Market Valued …
The Syringes and Needles Market was valued at US$ 8.27 billion in 2023 and is projected to reach US$ 13.59 billion by 2031, expanding at a CAGR of 6.4% during the forecast period 2024-2031. Syringes and needles are vital medical tools used for drug administration, vaccinations, and sample collection. Market growth is driven by rising healthcare demand, expanding immunization programs, and advancements in safety-engineered and disposable injection devices. ➠ Download Your Sample
Esterquats Market to Grow at 7.3% CAGR, Propelled by Key Players Evonik Industries AG, BASF SE, Stepan Company, Kao Corporation
Esterquats Market to Grow at 7.3% CAGR, Propelled by Key Players Evonik Industri …
The Esterquats Market size reached US$ 2.9 billion in 2023 and is expected to reach US$ 5.1 billion by 2031, growing with a CAGR of 7.3% from 2024 to 2031. Esterquats are biodegradable cationic surfactants derived from fatty acids and quaternary ammonium compounds, widely used for their superior conditioning, emulsifying, and softening properties. They serve as key ingredients in fabric softeners, hair care products, and personal care formulations. Growth is driven

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion